You are here: Home » News-CM » Companies » Results
Business Standard

Fredun Pharmaceuticals standalone net profit declines 39.34% in the June 2017 quarter

Capital Market 

Sales decline 44.55% to Rs 9.15 crore

Net profit of Fredun Pharmaceuticals declined 39.34% to Rs 0.37 crore in the quarter ended June 2017 as against Rs 0.61 crore during the previous quarter ended June 2016. Sales declined 44.55% to Rs 9.15 crore in the quarter ended June 2017 as against Rs 16.50 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales9.1516.50 -45 OPM %11.268.12 -PBDT0.670.96 -30 PBT0.450.76 -41 NP0.370.61 -39

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, August 12 2017. 17:27 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU